TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.580
-0.190 (-3.98%)
Sep 15, 2026, 11:45 AM EDT - Market open
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $282.01 million as of September 15, 2026. Its market cap has increased by 27.66% in one year.
Market Cap
282.01M
Enterprise Value
270.15M
1-Year Change
27.66%
Ranking
Category
Stock Price
$4.58
ChartMarket Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $282.01M, a decrease of -14.22%. That is a compound annual growth rate of -2.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 282.01M | -19.14% |
| Dec 31, 2025 | 348.75M | 128.28% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shoulder Innovations | 382.03M |
| Orthofix Medical | 371.07M |
| Viemed Healthcare | 336.70M |
| Mobia Medical | 333.91M |
| Perspective Therapeutics | 333.32M |
| CapsoVision | 325.81M |
| AVITA Medical | 315.14M |
| Treace Medical Concepts | 301.11M |